An international research team has succeeded in deciphering a key mechanism that controls the growth of pancreatic cancers.

Pancreatic cancer may evade the immune system using a clever molecular trick. Researchers found that the cancer-driving ...

Scientists may have found key to treating hidden cancer growths - Researchers say the findings offer a promising way to ...

MYC‑driven tumors silence innate immune alarms by clearing R‑loop–derived signals, exposing a new therapeutic angle for targeting MYC without broad inhibition.

Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers have now uncovered a hidden three-part loop that fuels tumor growth, ...

Could this mark a shift in how we think about cancer therapy? At least in the laboratory, evidence suggests it may be . An ...

The cancer gene MYC camouflages tumors by suppressing alarm signals that normally activate the immune system.

The growth protein, MYC, was consistently found with RBM42, which spurs MYC production, in human pancreatic tumors. Above, microscopy for MYC (red) and RBM42 (green) in a representative pancreatic ...

Please provide your email address to receive an email when new articles are posted on . Inhibiting RMB42 disrupted production of Myc proteins in pancreatic cancer cells. This approach could curtail ...

For decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many cancers manage to overcome this and continue growing. Now, UCSF scientists think ...